Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | VVD-130850 |
Synonyms | |
Therapy Description |
Limited information is currently available on VVD-130850, a putative STAT3 inhibitor (Jan 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
VVD-130850 | VVD 130850|VVD130850 | STAT3 Inhibitor 26 | Limited information is currently available on VVD-130850, a putative STAT3 inhibitor (Jan 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06188208 | Phase I | Pembrolizumab + VVD-130850 VVD-130850 | A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors | Recruiting | USA | ESP | AUS | 0 |